BioNanoSim (BNS) has developed a proprietary technology platform for the nano-encapsulation of drugs to improve delivery profile and therapeutic performance.
Research conducted by Professor Simon Benita and his team has demonstrated the potential of BNS's nano-encapsulation technology to design innovative routes of administration across a range of therapeutic areas including oncology, ophthalmology, and metabolic diseases. In addition, BNS is using its nano-encapsulation technologies to develop topical and ocular cannabis-based products.
Cumulative Funding Raised Over Time ($)
Employees Over Time
BioNanoSim Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jan 4, 2016
www.prnewswire.com
Immune Pharmaceuticals Announces New Data with Topical Cyclosporine Nano-Capsules in Dermatology